Bon Secours is nearing a roughly $6 billion takeover of Surgery Partners, the Financial Times reported on Sunday 25 October 2026. For anyone holding SGRY, the stock now trades against a possible cash exit whose per-share price has not been disclosed, rather than on its standalone business alone.
What did Bon Secours and Surgery Partners actually announce?
Nothing has been formally announced yet. According to the Financial Times on Sunday 25 October 2026, Bon Secours is nearing a takeover of Surgery Partners (ticker SGRY) valued at around $6 billion. Bloomberg and Seeking Alpha both carried the same FT-sourced report within the following hour.
The three newsrooms agree on three points and no more. The buyer is Bon Secours, the target is Surgery Partners, which is backed by Bain Capital, and the figure under discussion is around $6 billion. Everything past that is not yet established in public reporting.
What is confirmed versus what is not
- Confirmed by the headlines: buyer, target, Bain Capital ownership, an approximate $6 billion size, and that talks are advanced ("nears").
- Not yet known: the exact per-share price, whether the deal is all cash, the premium to Friday's close, the timeline, and whether a definitive agreement has been signed at all.
- Not yet known: financing structure, regulatory review path, or any break fee.
"Nears" is a deliberate word. It means talks are advanced, not that ink is on paper. Deals at this stage sometimes complete within days and sometimes collapse. Treat every number beyond the three facts above as an estimate until a company statement appears.
What does a $6 billion takeover mean for SGRY shareholders?
If a takeover is confirmed at a fixed price, the market value of SGRY shares tends to converge toward that offer price rather than toward where the business would trade on its own. That is the mechanical effect of an announced cash deal, and it is why acquisition targets usually gap up on the first trading day after a report.
Because the per-share price has not been reported, the size of any move is unknowable right now. What a holder can observe is the gap between Friday's closing price and whatever headline price eventually prints. Until a firm number exists, the $6 billion enterprise or equity figure is not the same as a per-share offer, and the two should not be conflated.
- A confirmed cash price typically caps the upside near that price and limits the downside unless the deal risks falling through.
- If the deal breaks, shares can fall back toward the pre-report level, sometimes sharply.
- The spread between the current price and the rumored or stated offer is what merger-arbitrage traders watch, and it reflects the market's view of completion odds.
None of this is a reason to act in any particular direction. It is simply how an announced acquisition reshapes the price mechanics of the target's stock.
How do I check whether I own Surgery Partners right now?
Open every portfolio and search for SGRY before you do anything else. Direct exposure is obvious, but indirect exposure through funds is easy to miss, and a healthcare-facilities or small-cap value ETF may hold Surgery Partners among its positions.
If you track holdings across several accounts, pull them into one view. PortfolioTrackr's ALL PORTFOLIOS combined view, available on every plan for anyone with more than one portfolio, shows the same ticker across accounts in a single line so you can see your total position at once. This matters on a weekend because you cannot trade until the market reopens, and the first question is simply how much you hold.
- Search each portfolio for the exact ticker SGRY.
- Check healthcare, small-cap and value ETFs for indirect exposure.
- Note your cost basis and current weight so you can read any opening move in context.
If you only ever look at your broker app, you may miss a holding sitting in another account entirely. This is one of the reasons many investors prefer a single tracker, as covered in our comparison of a portfolio tracker versus a spreadsheet.
How do I set a price alert on SGRY before the market reopens?
Set a watchlist level or a position target now so you hear within a minute of the price crossing it once trading resumes. On a breaking deal, the first prints after the open can move fast, and a level set in advance means you are not glued to a screen.
PortfolioTrackr checks every position and every watchlist level once a minute while the market is open, and around the clock for crypto. For a US-listed name like SGRY, that means checks run during regular market hours and you are notified within a minute of your level being reached. You can place a level on a position or add the ticker to a watchlist and set a price above or below.
- A watchlist entry takes a price above or a price below. The watchlist holds 10 tickers on the free trial and Starter, 50 on Pro and Lifetime.
- A position carries Target 1, Target 2 and a stop-loss level.
- Email, WhatsApp, Telegram and push alerts are on every plan; SMS is Pro and Lifetime only.
PortfolioTrackr reports status against your own levels, such as Target 1 reached or stop-loss level reached. It does not tell you what to do. Setting a level is a way to stay informed, not a trade instruction. There are no deal, news or event alerts, so the price level is the tool here.
How does merger news fit into reading your overall allocation?
A single-name deal is a prompt to check how much one position and one sector weigh in your total portfolio. If SGRY is a small line, a sharp move changes little for you; if it is concentrated, the same move matters far more.
Looking at weight rather than just the dollar change is the honest way to read this. A position that is 1% of your portfolio and one that is 15% react to identical news very differently in terms of your overall result. For a refresher on reading returns across periods, see our guide to reading portfolio returns across WTD, MTD, QTD and YTD windows.
A quick weekend checklist
- Confirm whether you hold SGRY directly or through a fund.
- Note the position's weight in your total portfolio.
- Decide what price levels you want to be told about and set the alerts.
- Watch for an official company statement with a firm per-share number.
Checking your exposure is not the same as deciding to trade. The point of the checklist is that you arrive at Monday's open already knowing your position and your levels, rather than reacting blind.
How are an announced deal and a mere report different?
A reported deal and a signed, announced deal are not the same thing, and the distinction drives how much certainty a price carries. The table below sets out what each stage typically gives an investor to work with.
| Stage | What is known | Price behavior |
|---|---|---|
| Report (where SGRY is now) | Buyer, target, approximate size | Gaps toward rumored value, high uncertainty |
| Definitive agreement | Exact per-share price, cash or stock, terms | Converges toward stated offer |
| Regulatory clearance | Approval path, closing timeline | Spread narrows as completion odds rise |
| Deal break | Reasons talks ended | Can fall back toward pre-report level |
As of Sunday 25 October 2026, Surgery Partners sits in the first row. The Financial Times, Bloomberg and Seeking Alpha reports describe talks that are near, not terms that are final.
What should SGRY holders watch next?
Watch for an official statement from Bon Secours, Surgery Partners or Bain Capital that puts a firm per-share number and deal structure on the record. That single document converts the current estimate into a price the market can anchor to.
- A definitive agreement with an exact price and whether it is cash or stock.
- Any regulatory commentary, since healthcare consolidation often draws review.
- The spread between the trading price and any stated offer, which signals how confident the market is in completion.
- Confirmation from the companies themselves, as all current reporting traces back to the FT.
If you hold the stock across more than one account and want everything in one place before the open, our walkthrough on connecting a brokerage account to a portfolio tracker covers the setup.
The bottom line
As of Sunday 25 October 2026, Bon Secours is reported to be nearing a roughly $6 billion takeover of Bain Capital-backed Surgery Partners, per the Financial Times, with Bloomberg and Seeking Alpha relaying the same account. No per-share price, structure or timeline is public yet.
For a holder, the useful moves this weekend are to confirm exposure to SGRY, note its weight, and set the price levels you want to be told about. PortfolioTrackr can surface your total position across accounts and alert you within a minute once the market reopens. The rest is waiting for an official statement with real numbers.
Sources
Frequently asked questions
Is the Bon Secours Surgery Partners deal confirmed?
Not formally. As of Sunday 25 October 2026, the Financial Times reported that Bon Secours is nearing a roughly $6 billion takeover of Surgery Partners, with Bloomberg and Seeking Alpha relaying the same account. No company has published a definitive agreement, per-share price or timeline yet.
How much is the Surgery Partners takeover worth?
The Financial Times reported a figure of around $6 billion on Sunday 25 October 2026. That is an overall deal size, not a per-share price, which has not been disclosed. Until the companies publish terms, the exact amount an SGRY shareholder would receive is unknown.
What happens to SGRY stock if the takeover is confirmed?
A confirmed cash takeover usually pushes the target's share price toward the agreed offer rather than its standalone value. The size of any move depends on the per-share price, which has not been reported. If talks collapse, shares can fall back toward the pre-report level.
How do I check if I own Surgery Partners across my accounts?
Search every portfolio for the ticker SGRY, including healthcare and small-cap ETFs that may hold it. PortfolioTrackr's ALL PORTFOLIOS combined view, on every plan for anyone with more than one portfolio, shows the same ticker across accounts on a single line so you see your total position at once.
Can I set a price alert on SGRY for Monday's open?
Yes. Add SGRY to a watchlist with a price above or below, or set Target 1, Target 2 or a stop-loss level on a position. PortfolioTrackr checks every level once a minute while the market is open and notifies you within a minute of your level being reached.